Loading...
Mitochondrial mutations and metabolic adaptation in pancreatic cancer
BACKGROUND: Pancreatic cancer has a five-year survival rate of ~8%, with characteristic molecular heterogeneity and restricted treatment options. Targeting metabolism has emerged as a potentially effective therapeutic strategy for cancers such as pancreatic cancer, which are driven by genetic altera...
Na minha lista:
| Udgivet i: | Cancer Metab |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5282905/ https://ncbi.nlm.nih.gov/pubmed/28163917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40170-017-0164-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|